Danieli Mayumi Kimura Leandro

Danieli Mayumi Kimura Leandro

Auto-generated profile, based on publicly available information

Danieli Mayumi Kimura Leandro

Irmandade da Santa Casa de Misericórdia de São Paulo, Department of Pediatrics, Division of Neonatology, São Paulo, SP, Brazil; Protecting Brains & Saving Futures, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo
Verified
Journal Article
Open access
PDF file
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
ANAlexandre Netto
Alexandre Netto
DRDaniela Pereira Rodrigues
Daniela Pereira Rodrigues
DLDanieli Mayumi Kimura Leandro
Danieli Mayumi Kimura Leandro
CFCarolina Nunes França
Carolina Nunes França
MMMarcelo Jenné Mimica
Marcelo Jenné Mimica
Background: Hypoxic-ischaemic encephalopathy (HIE) is a leading cause of long-term disability. Infants with HIE may require specific lifelong care, representing a devastating social and economic impact. Therapeutic hypothermia (TH) has been proven to be a safe and effective treatment; however, its potential economic impact associated with continuous electroencephalographic monitoring is still unknown in Brazil. This study aimed to evaluate the potential economic benefits provided by TH and continuous electroencephalographic monitoring in the first 20 years of life in infants with HIE in Brazil. Methods: A resource utilization questionnaire about healthcare of infants with HIE was answered by 57 pediatricians and neonatologists in all five regions of Brazil. This data was used to calculate an annual weighted average of patient management costs according to the presence or degree of disability, considering only directly related health costs. A mathematical calculation was performed considering local incidence of HIE and the number of live births per year. Rates of death and survival for different levels of disability and the effect of TH on these outcomes were estimated from the two most relevant randomized controlled trials on TH. Results: There was an approximately 26-fold increase in spending when the severe disability group was compared to the no disability group (p-value<0.0001, ANOVA-Bonferroni). The estimated total cost of patients with no disability, mild, moderate, and severe disability is US$ 6,808.53, US$ 32,208.43, US$ 105,791.78 and US$ 175,698.58, respectively, and the estimated costs related to the use of TH and neuromonitoring were estimated in US$ 2,824.00. Considering a weighted average between TOBY trial and NICHD trial, it is estimated annual savings of US$ 39,700,000-79,401,000. Conclusions: This study estimated a significant increase in the costs associated with the degree of disability and a positive impact of TH throughout the first 20 years of life. Keywords: Children with disability, Health care costs, Hypoxic-ischemic encephalopathy, Neonatal intensive care, Therapeutic hypothermia Resumo Introdução: A encefalopatia hipóxico-isquêmica (EHI) é uma das principais causas de deficiência incapacitante a longo prazo. Recém-nascidos (RN) com EHI podem necessitar de cuidados específicos ao longo da vida, representando um impacto social e econômico devastador. A hipotermia terapêutica (HT) é comprovadamente um tratamento seguro e eficaz; entretanto, seu potencial impacto econômico associado ao monitoramento eletroencefalográfico contínuo ainda é desconhecido no Brasil. Este estudo tem como objetivo avaliar os potenciais benefícios econômicos proporcionados pela HT e pela monitorização eletroencefalográfica contínua nos primeiros 20 anos de vida em lactentes com EHI no Brasil. Métodos: Um questionário de utilização de recursos sobre cuidados de saúde de crianças com EHI foi respondido por 57 pediatras e neonatologistas das cinco regiões do Brasil. Esses dados foram usados para calcular uma média anual ponderada dos custos de cuidados de saúde destes pacientes de acordo com a presença ou grau de incapacidade, considerando apenas custos de saúde diretos. Um cálculo matemático foi realizado considerando a incidência local de EHI e o número de nascidos vivos por ano. As taxas de mortalidade e de sobrevivência para diferentes níveis de incapacidade e o efeito da HT nestes resultados foram estimados a partir dos dois ensaios clínicos randomizados e controlados mais relevantes sobre a HT. Resultados: Houve um aumento de aproximadamente 26 vezes nos gastos quando o grupo com deficiência grave foi comparado ao grupo sem deficiência (p-valor<0,0001, ANOVA-Bonferroni). O custo total estimado para os pacientes sem incapacidade, com incapacidade leve, moderada e grave é de US$ 6.808,53, US$ 32.208,43, US$ 105.791,78 e US$ 175.698,58, respetivamente, e os custos estimados relacionados ao uso da HT e da neuromonitoramento foram estimados em US$ 2.824,00. Considerando uma média ponderada entre o estudo TOBY e o estudo NICHD, estima-se uma economia anual de US$ 39.700.000-79.401.000. Conclusões: Este estudo estimou um aumento significativo dos custos associados ao grau de incapacidade e um impacto positivo da HT ao longo dos primeiros 20 anos de vida. Palavras-chave: Crianças com deficiência, Custos de cuidados de saúde, Encefalopatia hipóxica-isquêmica, Terapia intensiva neonatal, Hipotermia induzida

15 June 2026 in Jornal de Pediatria
Verified
Journal Article
Open access
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
DLDanieli Mayumi Kimura Leandro
Danieli Mayumi Kimura Leandro
SASilvia Schoenau de Azevedo
Silvia Schoenau de Azevedo
MMMarcelo Jenné Mimica
Marcelo Jenné Mimica
MMMaurício Magalhães
Maurício Magalhães
VCValerie Y. Chock
Valerie Y. Chock
To identify the incidence, demographic characteristics, and risk factors for intraventricular hemorrhage (IVH) in preterm infants admitted to Brazilian neonatal intensive care units (NICUs). This prospective, observational cohort study was conducted over a one-year period in four NICUs in Brazil. All newborns with gestational age (GA) < 32 weeks or birth weight (BW) < 1500 g, born between September 2023 and September 2024, were included. Demographic data and short-term outcomes were collected. Multinomial logistic regression was performed to evaluate associations between clinical variables and IVH severity. A total of 268 newborns were enrolled. The mean BW and GA were 1138 g (SD ±388 g) and 29 weeks and 1 day (SD ±3 weeks), respectively. Normal cUS were seen in 54.1%, mild IVH in 20.5%, severe IVH in 10.4%, and 8.2% died prior to a cUS being performed. Infants with the outcome of severe IVH or death prior to cUS exhibited lower BW, GA, Apgar scores, rates of cesarean section, fewer complete courses of antenatal steroids, and were more likely to have undergone advanced resuscitation in the delivery room and significant interventions in the early neonatal period. Hypothermia was prevalent across all groups. Infants with severe IVH had significantly higher rates of death prior to hospital discharge and longer length of stay. Identifying risk factors for IVH is essential for developing strategies to optimize outcomes. Implementation of a standardized IVH prevention bundle in Brazilian NICUs focusing on factors shown to adversely affect outcomes is warranted.